What is it about?
Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer’s Disease
Featured Image
Why is it important?
Our findings indicate the existence of a little-known specific APOE-mediated mechanism that increases the plasma melatonin level in a subgroup of patients with AD who are carriers of the APOE ε4 allele.
Read the Original
This page is a summary of: Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer’s Disease, Current Alzheimer Research, July 2018, Bentham Science Publishers,
DOI: 10.2174/1567205015666180601090533.
You can read the full text:
Contributors
The following have contributed to this page
